Team:Braunschweig/Notebook
From 2013.igem.org
(Difference between revisions)
Line 89: | Line 89: | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
<b>Investigators: Kevin, Kerstin, Laura</b><br> | <b>Investigators: Kevin, Kerstin, Laura</b><br> | ||
- | We prepared some chemically competent XL1 blue E. Coli cells for all the transformations we are going to have to do during the project.</p> | + | We prepared some chemically competent XL1 blue <i>E. Coli</i> cells for all the transformations we are going to have to do during the project.</p> |
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px">Friday, May 24, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px">Friday, May 24, 2013</p> | ||
Line 96: | Line 96: | ||
<b>Investigators: Kevin, Kerstin, Laura</b><br> | <b>Investigators: Kevin, Kerstin, Laura</b><br> | ||
Today we transformed our freshly prepared competent cells for test purposes. We used the plasmids pUC 18 and pUC19 to calculate the transformation efficiency. 100 pg of DNA were used for each transformation with 50 µl cells. | Today we transformed our freshly prepared competent cells for test purposes. We used the plasmids pUC 18 and pUC19 to calculate the transformation efficiency. 100 pg of DNA were used for each transformation with 50 µl cells. | ||
- | Additionally, competent cells were plated on ampicillin, kanamycin and chloramphenicol to ensure that the strain is not carrying any corresponding resistances. The plates were incubated at 37 °C | + | Additionally, competent cells were plated on ampicillin, kanamycin and chloramphenicol to ensure that the strain is not carrying any corresponding resistances. The plates were incubated at 37 °C overnight.</p> |
Line 116: | Line 116: | ||
<div id="Week2" class="menuSection"> | <div id="Week2" class="menuSection"> | ||
<h2><a href="#Week2">Week 2: May 27 - June 1, 2013</a></h2> | <h2><a href="#Week2">Week 2: May 27 - June 1, 2013</a></h2> | ||
- | <p style="margin-left:5px; margin-right:5px;">The distribution kit arrived and we started with the actual labwork. 19 | + | <p style="margin-left:5px; margin-right:5px;">The distribution kit arrived and we started with the actual labwork. 19 BioBricks had to be transformed into our <i>E. coli</i> to secure the parts. Additionally we developed the cloning strategy for the next weeks.</p> |
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, May 27, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, May 27, 2013</p> | ||
Line 128: | Line 128: | ||
<b>Investigators: Tabea, Jan, Laura</b><br> | <b>Investigators: Tabea, Jan, Laura</b><br> | ||
The distribution kit arrived!<br> | The distribution kit arrived!<br> | ||
- | We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and | + | We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and transformed each BioBrick. This is the full list of BioBricks we planned on using in our project:<br> |
<img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/> | <img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/> | ||
Line 147: | Line 147: | ||
J23100<br> | J23100<br> | ||
- | We repeated the transformation of all the above listed BioBricks. However, we noticed that many of these parts | + | We repeated the transformation of all the above listed BioBricks. However, we noticed that many of these parts had an <i>ampR</i> backbone.</p> |
Line 165: | Line 165: | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
<b>Investigators: Kerstin, Kevin, Roman, Tabea</b><br> | <b>Investigators: Kerstin, Kevin, Roman, Tabea</b><br> | ||
- | We did a colony PCR | + | We did a colony PCR of the parts we secured so far. We got bands for all parts except for BioBricks C0061 and C0062. |
</p> | </p> | ||
Line 180: | Line 180: | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
<b>Investigators: Roman, Laura</b><br> | <b>Investigators: Roman, Laura</b><br> | ||
- | Since our transformations | + | Since our transformations of the BioBricks B0010, C0060, C0061, C0062, C0070, J23100 and J23106 were not successful, they amplified via Phusion-PCR directly from the resuspended DNA from the distribution kit.<br> |
We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in order to miniprep them the next day.</p> | We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in order to miniprep them the next day.</p> | ||
Line 188: | Line 188: | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
<b>Investigators: Oliver, Kerstin, Laura</b><br> | <b>Investigators: Oliver, Kerstin, Laura</b><br> | ||
- | <img alt="June3" src="https://static.igem.org/mediawiki/2013/d/d4/Braunschweig_Lab_Journal_June_3.png" width="250" align="right" vspace="0" hspace="20"/>We miniprepped the Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062 and R0071. As stated earlier the | + | <img alt="June3" src="https://static.igem.org/mediawiki/2013/d/d4/Braunschweig_Lab_Journal_June_3.png" width="250" align="right" vspace="0" hspace="20"/>We miniprepped the Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062 and R0071. As stated earlier the BioBricks C0061 and C0062 showed no visible bands in the colony PCR but we still prepped them. Furthermore we prepared glycerol stocks of all strains for further use.<br> |
- | Our gel electrophoresis of the PCR-amplified | + | Our gel electrophoresis of the PCR-amplified BioBricks showed a suitable bands for BioBricks C0060, C0061, C0070, J23100, J23106 which were recovered successfully from the gel. The BioBricks B0010, C0062 showed no bands on the gel and therefore could not be isolated. </p> |
Line 198: | Line 198: | ||
<b>Investigators: Laura, Kerstin</b><br> | <b>Investigators: Laura, Kerstin</b><br> | ||
- | We received the new set of BioBricks we ordered from the registry: B0015 (this one is going to be our new terminator, replacing the combination of B0010 and B0012), B0017, E0420, J23100, J23106. These were | + | We received the new set of BioBricks we ordered from the registry: B0015 (this one is going to be our new terminator, replacing the combination of B0010 and B0012), B0017, E0420, J23100, J23106. These were transformed via heatshock in <i>E. coli</i> XL1Blue MRF cells. We also prepared following of the miniprepped BioBricks for sequencing: C0061, B0012, B1009. The results are outlined in the following table: |
<img alt="June4" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Labjournal_June4.png" width="600" align="center" vspace="0" hspace="20"/> | <img alt="June4" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Labjournal_June4.png" width="600" align="center" vspace="0" hspace="20"/> | ||
</p> | </p> | ||
Line 207: | Line 207: | ||
<b>Investigators: Kerstin, Kevin, Oliver, Laura</b><br> | <b>Investigators: Kerstin, Kevin, Oliver, Laura</b><br> | ||
<img alt="June5" src="https://static.igem.org/mediawiki/2013/8/80/Braunschweig_Lab_Journal_June_5.png" width="250" align="right" vspace="0" hspace="20"/> | <img alt="June5" src="https://static.igem.org/mediawiki/2013/8/80/Braunschweig_Lab_Journal_June_5.png" width="250" align="right" vspace="0" hspace="20"/> | ||
- | Since we were not able to transform the BioBricks B0015, J23100 and J23106 we decided to obtain these Bricks via Phusion-PCR directly from resuspended DNA from the | + | Since we were not able to transform the BioBricks B0015, J23100 and J23106 we decided to obtain these Bricks via Phusion-PCR directly from resuspended DNA from the distribution kit.<br> |
- | A gel electrophoresis was conducted with the freshly acquired PCR products of B0015, J23100 and J23106 as well as C0060, C0061, C0070, J23100 and J23106 from our last batch of PCR amplificates. Besides J23100 from today's PCR all | + | A gel electrophoresis was conducted with the freshly acquired PCR products of B0015, J23100 and J23106 as well as C0060, C0061, C0070, J23100 and J23106 from our last batch of PCR amplificates. Besides J23100 from today's PCR all BioBricks showed bands of the expected size that were isolated via gel extraction. |
</p> | </p> | ||
Line 215: | Line 215: | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
<b>Investigators: Oliver, Laura</b><br> | <b>Investigators: Oliver, Laura</b><br> | ||
- | We prepared to clone some of our first and essential parts. The | + | We prepared to clone some of our first and essential parts. The BioBricks were digested according to the table below. |
- | Parts labeled as vector were dephosphorylated to prevent religation and purified.<br> | + | Parts labeled as vector were dephosphorylated to prevent religation and then purified.<br> |
- | In order to obtain the inserts a gel electrophoresis was conducted and the appropriate band was isolated by gel extraction.The ligations were conducted according to the following table. | + | In order to obtain the inserts a gel electrophoresis was conducted and the appropriate band was isolated by gel extraction. The ligations were conducted according to the following table. |
<img alt="June6" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Lab_Journal_June_6.png" width="600" align="center" vspace="0" hspace="20"/></p> | <img alt="June6" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Lab_Journal_June_6.png" width="600" align="center" vspace="0" hspace="20"/></p> | ||
Line 467: | Line 467: | ||
Transformation of the eforRed expression cassette in <i>E. coli</i> Top10 was performed by electroporation.<br> | Transformation of the eforRed expression cassette in <i>E. coli</i> Top10 was performed by electroporation.<br> | ||
- | The reporter strains for the Las and Rhl systems (<i>E. coli</i> JM109 pSB1075 and <i>E. coli JM109 pSB406 respectively) arrived today. Liquid cultures in 2xYT containing ampicillin were inoculated and grown at 37°C and 250 rpm overnight.<br> | + | The reporter strains for the Las and Rhl systems (<i>E. coli</i> JM109 pSB1075 and <i>E. coli</i> JM109 pSB406 respectively) arrived today. Liquid cultures in 2xYT containing ampicillin were inoculated and grown at 37°C and 250 rpm overnight.<br> |
- | Pre-cultures of <i>E. coli</i> Top10F’ containing finale pRhl inducible construct and E. coli XL1 containing finale pLas inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.</p> | + | Pre-cultures of <i>E. coli</i> Top10F’ containing finale pRhl inducible construct and <i>E. coli</i> XL1 containing finale pLas inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.</p> |
Revision as of 09:10, 2 October 2013
Labjournal
This is the documentation of our lab work. An overview on how we approached this project can be found under Approach. For detailed protocols of certain procedures please refer to Protocols. Attributions are given for each day, however please check our Attributions section for efforts beyond the lab work.
Our sponsors